Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of 2.5, 5 and 10 mg
doses of mifepristone against a placebo in women with laparoscopic diagnostic of
endometriosis.
The hypothesis of the study is that the 5 mg mifepristone dose is safe and effective and
should be used in future studies on medical treatment of endometriosis.